Piracetam prevents scopolamine-induced memory impairment and decrease of NTPDase, 5′-nucleotidase and adenosine deaminase activities

Neurochemical Research

Volumn 38, Issue 8, 2013, Pages 1704-1714

  Marisco, Patricia C ^a   Carvalho, Fabiano B ^a   Rosa, Michelle M ^a   Girardi, Bruna A ^a   Gutierres, Jessié M ^a   Jaques, Jeandre A S ^a   Salla, Ana P S ^a   Pimentel, Víctor C ^a   Schetinger, Maria Rosa C ^a   Leal, Daniela B R ^a   Mello, Carlos F ^a   Rubin, Maribel A ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

5 Nucleotidase; Adenosine deaminase; Memory; NTPDase; Oxidative stress; Piracetam

Indexed keywords

5' NUCLEOTIDASE; ADENINE NUCLEOTIDE; ADENOSINE DEAMINASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; PHOSPHATASE; PIRACETAM; SCOPOLAMINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN CORTEX; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; HIPPOCAMPUS; HYDROLYSIS; IN VITRO STUDY; MALE; MEMORY DISORDER; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE METABOLISM; OXIDATIVE STRESS; PRIORITY JOURNAL; RECOGNITION; SYNAPTOSOME; TRAINING;

5'-NUCLEOTIDASE; ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE TRIPHOSPHATE; ANIMALS; BEHAVIOR, ANIMAL; MALE; MEMORY DISORDERS; NEUROPROTECTIVE AGENTS; PIRACETAM; PYROPHOSPHATASES; RATS; RATS, WISTAR; SCOPOLAMINE HYDROBROMIDE; SYNAPTOSOMES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA;

EID: 84879692255     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-013-1072-6     Document Type: Article

References (81)

1. Winblad B (2005) Piracetam: a review of pharmacological properties and clinical uses. CNS Drug Rev 11(2):169-182
2. Croisile B, Trillet M, Fondarai J, Laurent B, Mauguiere F, Billardon M (1993) Long-term and high-dose piracetam treatment of Alzheimer's disease. Neurology 43(2):301-305
3. Fedi M, Reutens D, Dubeau F, Andermann E, D'Agostino D, Andermann F (2001) Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy. Arch Neurol 58(5):781-786
4. Kessler J, Thiel A, Karbe H, Heiss WD (2000) Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. Stroke 31(9):2112-2116
5. Malykh AG, Sadaie MR (2010) Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders. Drugs 70(3):287-312
6. Gualtieri F, Manetti D, Romanelli MN, Ghelardini C (2002) Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs. Curr Pharm Des 8(2):125-138
7. Chopin P, Briley M (1992) Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats. Psychopharmacology 106(1):26-30
8. Piercey MF, Vogelsang GD, Franklin SR, Tang AH (1987) Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: implications regarding identification of brain structures involved in consolidation of memory traces. Brain Res 424(1):1-9
9. Verloes R, Scotto AM, Gobert J, Wulfert E (1988) Effects of nootropic drugs in a scopolamine-induced amnesia model in mice. Psychopharmacology 95(2):226-230
10. Gabryel B, Trzeciak HI (1994) Nootropics: pharmacological properties and therapeutic use. Pol J Pharmacol 46(5):383-394
11. Eckert GP, Cairns NJ, Muller WE (1999) Piracetam reverses hippocampal membrane alterations in Alzheimer's disease. J Neural Transm 106(7-8):757-761
12. Leuner K, Kurz C, Guidetti G, Orgogozo JM, Muller WE (2010) Improved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetam. Front Neurosci 4(44):1-11
13. Muller WE, Koch S, Scheuer K, Rostock A, Bartsch R (1997) Effects of piracetam on membrane fluidity in the aged mouse, rat, and human brain. Biochem Pharmacol 53(2):135-140
14. Peuvot J, Schanck A, Deleers M, Brasseur R (1995) Piracetam-induced changes to membrane physical properties. A combined approach by 31P nuclear magnetic resonance and conformational analysis. Biochem Pharmacol 50(8):1129-1134
15. Ahmed AH, Oswald RE (2010) Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors. J Med Chem 53(5):2197-2203
16. Ito I, Tanabe S, Kohda A, Sugiyama H (1990) Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J Physiol 424:533-543
17. Gabryel B, Adamek M, Pudelko A, Malecki A, Trzeciak HI (2002) Piracetam and vinpocetine exert cytoprotective activity and prevent apoptosis of astrocytes in vitro in hypoxia and reoxygenation. Neurotoxicology 23(1):19-31
18. Keil U, Scherping I, Hauptmann S, Schuessel K, Eckert A, Muller WE (2006) Piracetam improves mitochondrial dysfunction following oxidative stress. Br J Pharmacol 147(2):199-208
19. Moriau M, Crasborn L, Lavenne-Pardonge E, von Frenckell R, Col-Debeys C (1993) Platelet anti-aggregant and rheological properties of piracetam. A pharmacodynamic study in normal subjects. Arzneimittelforschung 43(2):110-118
20. Lamberty Y, Detrait E, Leclercq K, Michel A, De Ryck M (2009) Behavioural phenotyping reveals anxiety-like features of SV2A deficient mice. Behav Brain Res 198(2):329-333
21. Blokland A (1995) Acetylcholine: a neurotransmitter for learning and memory? Brain Res Brain Res Rev 21(3):285-300
22. Klinkenberg I, Blokland A (2010) The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev 34(8):1307-1350. doi: 10.1016/j.neubiorev.2010. 04.001
23. Goverdhan P, Sravanthi A, Mamatha T (2012) Neuroprotective effects of meloxicam and selegiline in scopolamine-induced cognitive impairment and oxidative stress. Int J Alzheimers Dis 2012:974013. doi: 10.1155/2012/974013
24. Fan Y, Hu J, Li J, Yang Z, Xin X, Wang J, Ding J, Geng M (2005) Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms. Neurosci Lett 374(3):222-226. doi: 10.1016/j.neulet.2004.10.063
25. Ray CA, Blin J, Chase TN, Piercey MF (1992) Effects of cholinergic agonists on regional brain energy metabolism in the scopolamine-treated rat. Neuropharmacology 31(11):1193-1199
26. Zimmermann H (1996) Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system. Prog Neurobiol 49(6):589-618
27. Zimmermann H (1992) 5′-Nucleotidase: molecular structure and functional aspects. Biochem J 285(Pt 2):345-365
28. Dunwiddie TV, Haas HL (1985) Adenosine increases synaptic facilitation in the in vitro rat hippocampus: evidence for a presynaptic site of action. J Physiol 369:365-377
29. Gomes CV, Kaster MP, Tome AR, Agostinho PM, Cunha RA (2011) Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. Biochim Biophys Acta 1808(5):1380-1399
30. Robson SC, Sevigny J, Zimmermann H (2006) The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2(2):409-430
31. Cunha RA, Vizi ES, Ribeiro JA, Sebastiao AM (1996) Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J Neurochem 67(5):2180-2187
32. Phillis JW, Wu PH (1981) The role of adenosine and its nucleotides in central synaptic transmission. Prog Neurobiol 16(3-4):187-239
33. Ribeiro JA (1999) Adenosine A2A receptor interactions with receptors for other neurotransmitters and neuromodulators. Eur J Pharmacol 375(1-3):101-113
34. Richardson PJ, Brown SJ (1987) ATP release from affinity-purified rat cholinergic nerve terminals. J Neurochem 48(2):622-630
35. Fujii S (2004) ATP- and adenosine-mediated signaling in the central nervous system: the role of extracellular ATP in hippocampal long-term potentiation. J Pharmacol Sci 94(2):103-106
36. Fujii S, Kato H, Kuroda Y (2002) Cooperativity between extracellular adenosine 5′-triphosphate and activation of N-methyl-d-aspartate receptors in long-term potentiation induction in hippocampal CA1 neurons. Neuroscience 113(3):617-628
37. 2+](i) during adenosine triphosphate-induced synaptic plasticity in hippocampal CA1 neurons of the guinea pig. Neurosci Lett 324(1):65-68
38. Wieraszko A, Ehrlich YH (1994) On the role of extracellular ATP in the induction of long-term potentiation in the hippocampus. J Neurochem 63(5):1731-1738
39. Wieraszko A (1996) Extracellular ATP as a neurotransmitter: its role in synaptic plasticity in the hippocampus. Acta Neurobiol Exp (Wars) 56(2):637-648
40. Almeida T, Rodrigues RJ, de Mendonca A, Ribeiro JA, Cunha RA (2003) Purinergic P2 receptors trigger adenosine release leading to adenosine A2A receptor activation and facilitation of long-term potentiation in rat hippocampal slices. Neuroscience 122(1):111-121
41. Costenla AR, de Mendonca A, Ribeiro JA (1999) Adenosine modulates synaptic plasticity in hippocampal slices from aged rats. Brain Res 851(1-2):228-234
42. Arai A, Kessler M, Lynch G (1990) The effects of adenosine on the development of long-term potentiation. Neurosci Lett 119(1):41-44
43. de Mendonca A, Ribeiro JA (1997) Adenosine and neuronal plasticity. Life Sci 60(4-5):245-251
44. Wieraszko A, Goldsmith G, Seyfried TN (1989) Stimulation-dependent release of adenosine triphosphate from hippocampal slices. Brain Res 485(2):244-250
45. Burnstock G, Fredholm BB, Verkhratsky A (2011) Adenosine and ATP receptors in the brain. Curr Top Med Chem 11(8):973-1011
46. Zhang DS, Ren LM (2003) Effect of adenosine A1 receptor antagonist on learning and memory and analysis of its mechanism. Yao Xue Xue Bao 38(6):416-419
47. Suzuki F, Shimada J, Shiozaki S, Ichikawa S, Ishii A, Nakamura J, Nonaka H, Kobayashi H, Fuse E (1993) Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl) adenosine-induced cognitive disturbance. J Med Chem 36(17):2508-2518
48. Botton PH, Costa MS, Ardais AP, Mioranzza S, Souza DO, da Rocha JB, Porciuncula LO (2010) Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice. Behav Brain Res 214(2):254-259
49. Prediger RD, Takahashi RN (2005) Modulation of short-term social memory in rats by adenosine A1 and A(2A) receptors. Neurosci Lett 376(3):160-165
50. Prediger RD, Fernandes D, Takahashi RN (2005) Blockade of adenosine A2A receptors reverses short-term social memory impairments in spontaneously hypertensive rats. Behav Brain Res 159(2):197-205
51. Cunha GM, Canas PM, Melo CS, Hockemeyer J, Muller CE, Oliveira CR, Cunha RA (2008) Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801. Exp Neurol 210(2):776-781
52. Kopf SR, Melani A, Pedata F, Pepeu G (1999) Adenosine and memory storage: effect of A(1) and A(2) receptor antagonists. Psychopharmacology 146(2):214-219
53. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, San Diego
54. Guerra GP, Mello CF, Bochi GV, Pazini AM, Rosa MM, Ferreira J, Rubin MA (2012) Spermidine-induced improvement of memory involves a cross-talk between protein kinases C and A. J Neurochem 122:363-373
55. Rubin MA, Berlese DB, Stiegemeier JA, Volkweis MA, Oliveira DM, dos Santos TL, Fenili AC, Mello CF (2004) Intra-amygdala administration of polyamines modulates fear conditioning in rats. J Neurosci 24(9):2328-2334
56. Ennaceur A, Delacour J (1988) A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav Brain Res 31:47-59
57. Velloso NA, Dalmolin GD, Gomes GM, Rubin MA, Canas PM, Cunha RA, Mello CF (2009) Spermine improves recognition memory deficit in a rodent model of Huntington's disease. Neurobiol Learn Mem 92(4):574-580
58. Dunkley PR, Jarvie PE, Robinson PJ (2008) A rapid Percoll gradient procedure for preparation of synaptosomes. Nat Protoc 3(11):1718-1728. doi: 10.1038/nprot.2008.171
59. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
60. Schetinger MR, Porto NM, Moretto MB, Morsch VM, da Rocha JB, Vieira V, Moro F, Neis RT, Bittencourt S, Bonacorso HG, Zanatta N (2000) New benzodiazepines alter acetylcholinesterase and ATPDase activities. Neurochem Res 25(7):949-955
61. Heymann D, Reddington M, Kreutzberg GW (1984) Subcellular localization of 5′-nucleotidase in rat brain. J Neurochem 43(4):971-978
62. 2+-stimulated ATPase activity. Anal Biochem 157(2):375-380
63. Guisti G, Galanti B (1984) Methods of enzymatic analises. VerlagChemie, Weinheim, pp 315-323
64. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351-358
65. Lenegre A, Chermat R, Avril I, Steru L, Porsolt RD (1988) Specificity of piracetam's anti-amnesic activity in three models of amnesia in the mouse. Pharmacol Biochem Behav 29(3):625-629
66. Schindler U (1989) Pre-clinical evaluation of cognition enhancing drugs. Prog Neuropsychopharmacol Biol Psychiatry 13(Suppl):S99-S115
67. Izquierdo I (1989) Mechanism of action of scopolamine as an amnestic. Trends Pharmacol Sci 10(5):175-177
68. McDaniel MA, Maier SF, Einstein GO (2003) "Brain-specific" nutrients: a memory cure? Nutrition 19(11-12):957-975
69. El-Sherbiny DA, Khalifa AE, Attia AS, Eldenshary Eel D (2003) Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol Biochem Behav 76(3-4):525-533
70. Giridharan VV, Thandavarayan RA, Konishi T (2011) Effect of Shengmai-san on cognitive performance and cerebral oxidative damage in BALB/c mice. J Med Food 14(6):601-609. doi: 10.1089/jmf.2010.1362
71. Konar A, Shah N, Singh R, Saxena N, Kaul SC, Wadhwa R, Thakur MK (2011) Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells. PLoS ONE 6(11):e27265
72. Jeong EJ, Lee KY, Kim SH, Sung SH, Kim YC (2008) Cognitive-enhancing and antioxidant activities of iridoid glycosides from Scrophularia buergeriana in scopolamine-treated mice. Eur J Pharmacol 588(1):78-84
73. Kaczmarek E, Koziak K, Sevigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, Robson SC (1996) Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem 271(51):33116-33122
74. Candinas D, Koyamada N, Miyatake T, Siegel J, Hancock WW, Bach FH, Robson SC (1996) Loss of rat glomerular ATP diphosphohydrolase activity during reperfusion injury is associated with oxidative stress reactions. Thromb Haemost 76(5):807-812
75. Gutierres JM, Kaizer RR, Schmatz R, Mazzanti CM, Vieira JM, Rodrigues MV, Jaques J, Carvalho F, Zanini D, Morsch VM, Schetinger MR, Spanevello RM (2012) alpha-Tocopherol regulates ectonucleotidase activities in synaptosomes from rats fed a high-fat diet. Cell Biochem Funct 30:286-292
76. Jaques JA, Rezer JF, Goncalves JF, Spanevello RM, Gutierres JM, Pimentel VC, Thome GR, Morsch VM, Schetinger MR, Leal DB (2011) The effect of curcumin in the ectonucleotidases and acetylcholinesterase activities in synaptosomes from the cerebral cortex of cigarette smoke-exposed rats. Cell Biochem Funct 29(8):703-707. doi: 10.1002/cbf.1804
77. Abdel-Salam OM, Khadrawy YA, Salem NA, Sleem AA (2011) Oxidative stress in a model of toxic demyelination in rat brain: the effect of piracetam and vinpocetine. Neurochem Res 36(6):1062-1072
78. Kurz C, Ungerer I, Lipka U, Kirr S, Schutt T, Eckert A, Leuner K, Muller WE (2010) The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by beta-amyloid peptide. Br J Pharmacol 160(2):246-257
79. Pereira GS, Rossato JI, Sarkis JJ, Cammarota M, Bonan CD, Izquierdo I (2005) Activation of adenosine receptors in the posterior cingulate cortex impairs memory retrieval in the rat. Neurobiol Learn Mem 83(3):217-223
80. Pereira GS, Mello e Souza T, Vinade ER, Choi H, Rodrigues C, Battastini AM, Izquierdo I, Sarkis JJ, Bonan CD (2002) Blockade of adenosine A1 receptors in the posterior cingulate cortex facilitates memory in rats. Eur J Pharmacol 437(3):151-154
81. Hauber W, Bareiss A (2001) Facilitative effects of an adenosine A1/A2 receptor blockade on spatial memory performance of rats: selective enhancement of reference memory retention during the light period. Behav Brain Res 118(1):43-52